A University of Houston pharmacology researcher and expert in cardiac development has identified a new cause of—and repair ...

Non-compaction cardiomyopathy is a heart condition caused by defects that arise during fetal development and can have diverse health impacts in affected individuals, including sudden cardiac death.

Non-compaction cardiomyopathy is a heart condition caused by defects that arise during fetal development and can have diverse health impacts in affected individuals, including sudden cardiac death.

Loss-of-function in epicardial proteins called Numb Family Proteins, leads to left ventricular noncompaction, or spongy heart, presenting ...

University of Houston pharmacologist Mingfu Wu has been awarded $2.5 million from the National Heart, Lung, and Blood Institute to explore the cause of and therapeutic treatment for left ventricular ...

Having explored how the heart is formed in utero, a University of Houston pharmacology researcher is reporting how cells and molecules act during that early formation and what might cause the heart ...

The researchers found that MYH7, MYBPC3, and TTN mutations were the most common mutations (71%) found in genetic NCCM. HealthDay News — Genetic stratification should play a role in clinical care of ...

A change in clinical practice could bring benefits for young elite athletes with the use of a novel new screening tool for cardiomyopathy, a cardiac condition that researchers said was "frequently ...

March 5, 2012 (Vienna, Austria) — Cardiac magnetic resonance imaging (MRI) can be a valuable diagnostic tool for patients with acute chest pain and elevated cardiac enzymes who have a negative ...

Hypertrophic cardiomyopathy (HCM) is the most common inherited form of heart disease, associated with over 1,000 mutations, many in β-cardiac myosin (MYH7). Molecular studies of myosin with different ...

Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window "Medical Journeys" is a set of clinical resources reviewed by ...

A University of Houston pharmacology researcher and expert in cardiac development has identified a new cause of - and repair ...